DEATH MIGHT BE CHEAPER

Critics have raised concerns about the American medical system's high costs and limited availability, with recent events exacerbating these issues. Robert Kennedy Jr. highlighted the consequences of cutting $500 million in research funding for mRNA vaccines, which could have protected people from harm.

Additionally, President Trump's proposed tariffs on Australian pharmaceuticals, aimed at making Americans pay more for essential medicines, could further harm citizens. Dennis Fitzgerald from Melbourne, Australia, warns that these actions could negatively impact American citizens who may struggle to afford necessary healthcare.

The article underscores the importance of addressing these challenges in the healthcare system to ensure access to affordable and effective medical treatments.